Semaphorins and plexins as therapeutic targets
Crossref DOI link: https://doi.org/10.1038/nrd4337
Published Online: 2014-08-01
Published Print: 2014-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Worzfeld, Thomas
Offermanns, Stefan
Text and Data Mining valid from 2014-08-01
Article History
First Online: 1 August 2014
Competing interests
: T.W. and S.O. hold a patent on B-type plexin antagonists and uses thereof.